Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Ovarian Epithelial × Radiosurgery × Clear all

Phase

Status

Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 28 Brain Neoplasms 24 Neoplasm Metastasis 19 Carcinoma, Non-Small-Cell Lung 15 Lung Neoplasms 14 Breast Neoplasms 12 Melanoma 10 Carcinoma, Hepatocellular 10 Carcinoma, Renal Cell 8 Colorectal Neoplasms 7 Neoplasms 6 Pancreatic Neoplasms 5 Spinal Cord Neoplasms 3 Prostate Cancer Metastatic 3 Kidney Neoplasms 3 Urinary Bladder Neoplasms 2 Unresectable Locally Recurrent Rectal Cancer 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Radiation Injuries 2 Osteosarcoma 2 Oligometastatic Prostate Cancer 2 Neuroma, Acoustic 2 Neoplasms by Site 2 NSCLC 2 Meningioma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2

Interventions

Paclitaxel 10 pembrolizumab 5 Carboplatin 5 Bevacizumab 5 olaparib 3 liposomal doxorubicin 3 ribociclib 2 palbociclib 2 mirvetuximab soravtansine 2 fludarabine 2 Topotecan 2 Letrozole 2 Fulvestrant 2 Cyclophosphamide 2 Blood Specimen Collection 2 trastuzumab deruxtecan 1 sacituzumab govitecan 1 pegfilgrastim 1 niraparib 1 lenvatinib 1 isoquercitrin 1 fludarabine phosphate 1 durvalumab 1 denileukin diftitox 1 cemiplimab 1 abemaciclib 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 SLC25A33 protein, human 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05444270 2023-11-24

SABR-ROC

Yonsei University

Phase NA Recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡